FDA TO ACCELERATE DRUG TRIALS WITH AI AND REAL-TIME DATA

The FDA is implementing real-time data monitoring and AI tools to reduce clinical trial timelines for new medications. The agency aims to give drug companies greater visibility into ongoing trials to expedite the approval process.